About Technology Issues FAQ

Links

Official Page

Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma

Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.